tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Li Watsek, 58 are a BUY (95.08%), 3 are a HOLD (4.92%).
Analyst Li Watsek works at CANTOR FITZGERALD with a stock forecast success ratio of 17.88% fulfilled within 71 days on average.
Li Watsek’s has documented 116 price targets and ratings displayed on 16 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on ASND, Ascendis Pharma AS at 18-Apr-2024.
Analyst best performing recommendations are on FATE (FATE THERAPEUTICS).
The best stock recommendation documented was for CRVS (CORVUS PHARMACEUTICALS) at 8/3/2021. The price target of $5 was fulfilled within 45 days with a profit of $2.9 (138.1%) receiving and performance score of 30.69.
Average potential price target upside
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
4
23 days ago
1/4 (25%)
$2.36 (143.90%)
45
Buy
12
$10.56 (733.33%)
10
9 months 14 days ago
1/3 (33.33%)
$9.03 (304.04%)
216
Hold
3.5
$2.06 (143.06%)
3.5
10 months 8 days ago
5/7 (71.43%)
$1.26 (56.25%)
302
Buy
8
$6.54 (447.95%)
2 years 4 months 23 days ago
0/1 (0%)
$4.69 (141.69%)
Buy
5
3 years 6 months 19 days ago
2/4 (50%)
$2.85 (132.56%)
313
Which stock is Li Watsek is most bullish on?
Which stock is Li Watsek is most reserved on?
What Year was the first public recommendation made by Li Watsek?
